rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8-9
|
pubmed:dateCreated |
2010-9-14
|
pubmed:abstractText |
Trastuzumab is an established component of breast cancer combination regimens, but data on the safety and efficacy of single-agent therapy is sparse.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/HER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1423-0240
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
425-30
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20838057-Adolescent,
pubmed-meshheading:20838057-Adult,
pubmed-meshheading:20838057-Aged,
pubmed-meshheading:20838057-Antibodies, Monoclonal,
pubmed-meshheading:20838057-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20838057-Antineoplastic Agents,
pubmed-meshheading:20838057-Breast Neoplasms,
pubmed-meshheading:20838057-Carcinoma,
pubmed-meshheading:20838057-Female,
pubmed-meshheading:20838057-Germany,
pubmed-meshheading:20838057-Humans,
pubmed-meshheading:20838057-Middle Aged,
pubmed-meshheading:20838057-Receptor, erbB-2,
pubmed-meshheading:20838057-Treatment Outcome,
pubmed-meshheading:20838057-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Trastuzumab single-drug therapy after failure of cytotoxic treatment for metastatic breast cancer.
|
pubmed:affiliation |
Klinikum Mutterhaus der Borromäerinnen gGmbH, Trier, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|